Skip to content

Assessing the efficacy of a stepped care treatment program for Borderline Personality Disorder

A randomised control trial assessing the efficacy of stepped care psychological treatment versus treatment as usual for Borderline Personality Disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618000477224
Acronym
Nil known
Enrollment
121
Registered
2018-04-03
Start date
2018-07-03
Completion date
2020-06-30
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

People meeting the criteria for Borderline Personality Disorder have a variety of mental health and psychosocial difficulties. The disorder can have a significant burden on the person's partner and family and can lead to high costs to health services if left untreated.. Approximately 10% of clients with Borderline Personality Disorder die by suicide. Costs to the health service include a high number of emergency department presentations and hospital beds occupied by people with this condition. Psychological therapy is the mainstay of treatment of borderline personality disorder; However, the demand for psychological treatment has resulted in excessive waitlists for a high risk cohort. This study aims to investigate the effectiveness of a stepped care group program compared to tailored individual care.

Interventions

The intervention is a stepped care group treatment program. Following diagnostic assessment confirming trial eligibility participants will then be randomised to either stepped care group treatment or tailored individual treatment. The stepped care group treatment will involve two phases: an initial 12 week phase, followed by an extended 16 week phase. Not all participants will proceed from the initial to the extended phase. Criteria for continuing to the extended phase is continuing to meet diag

The intervention is a stepped care group treatment program. Following diagnostic assessment confirming trial eligibility participants will then be randomised to either stepped care group treatment or tailored individual treatment. The stepped care group treatment will involve two phases: an initial 12 week phase, followed by an extended 16 week phase. Not all participants will proceed from the initial to the extended phase. Criteria for continuing to the extended phase is continuing to meet diagnostic criteria for BPD (> 4 criteria) or severity on GAF < 65 at completion of the initial phase. The group intervention is a skills training (GST) program. The first phase of group treatment will involve 12 consecutive weekly, 2 hour sessions. The second phase of group treatment will provide 1 x 2 hour sessions for 16 consecutive weeks. The groups will be facilitated by 2 psychologists. The GST program is a skills based therapy that includes four modules: mindfulness (focusing on the 'here and now'), crisis coping skills, skills in how to identify and manage emotions and skills for improving interpersonal communication and relationship building.

Sponsors

Illawarra Shoalhaven Local Health District
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Formal diagnosis of Borderline Personality Disorder

Exclusion criteria

Non English speaking Acute psychotic disorder Unable to participate due to current drug and alcohol use Participant requires a higher level of care than provided in the intervention, e.g. inpatient admission

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 22, 2026